Today, the Shanghai Stock Exchange and China Securities Index Co., Ltd. will officially release the SSE Innovative Pharmaceutical Science and Technology Innovation Leading Index and the Shanghai Science and Technology Innovation Board Software Service Index to provide investors with richer investment targets. The Shanghai Science and Technology Innovation Leading Index selected 40 securities of listed companies in the field of innovative pharmaceuticals with a high level of R&D and good growth from companies listed on the Science and Technology Innovation Board and the Shanghai Securities Main Board as an index sample; the Shanghai Science and Technology Innovation Board Software Service Index selected 40 securities of listed companies in the field of software development and software services from the Science and Technology Innovation Board as a sample. The launch of the two indices not only helped increase the sample weight of the Science and Technology Innovation Board, but also provided investors with new benchmark tools to observe the two high growth tracks of innovative drugs and software services, and accelerate market value discovery.

Today, the Shanghai Stock Exchange and China Securities Index Co., Ltd. will officially release the SSE Innovative Pharmaceutical Science and Technology Innovation Leading Index and the Shanghai Science and Technology Innovation Board Software Service Index to provide investors with richer investment targets. The Shanghai Science and Technology Innovation Leading Index selected 40 securities of listed companies in the field of innovative pharmaceuticals with a high level of R&D and good growth from companies listed on the Science and Technology Innovation Board and the Shanghai Securities Main Board as an index sample; the Shanghai Science and Technology Innovation Board Software Service Index selected 40 securities of listed companies in the field of software development and software services from the Science and Technology Innovation Board as a sample. The launch of the two indices not only helped increase the sample weight of the Science and Technology Innovation Board, but also provided investors with new benchmark tools to observe the two high growth tracks of innovative drugs and software services, and accelerate market value discovery.